Spots Global Cancer Trial Database for metastatic osteosarcoma
Every month we try and update this database with for metastatic osteosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma | NCT05235165 | Metastatic Mali... Metastatic Oste... Osteosarcoma | Biospecimen Col... Computed Tomogr... Questionnaire A... Thoracoscopy Thoracotomy | - 50 Years | Children's Oncology Group | |
| Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma | NCT00005625 | Sarcoma | trabectedin | 12 Years - | Memorial Sloan Kettering Cancer Center | |
| Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma | NCT02484443 | Metastatic Mali... Metastatic Oste... Recurrent Osteo... | Dinutuximab Laboratory Biom... Pharmacological... Sargramostim | - 29 Years | National Cancer Institute (NCI) | |
| Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma | NCT01374672 | Localized Osteo... Metastatic Oste... Osteoblastic Os... Recurrent Osteo... | laboratory biom... | 10 Years - 20 Years | Children's Oncology Group | |
| Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery | NCT01553539 | Bone Cancer Chondrosarcoma Clear Cell Sarc... Metastatic Oste... Ovarian Sarcoma Recurrent Adult... Recurrent Osteo... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin... | therapeutic ang... laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs | NCT06228326 | Lung Cancer, No... Lung Cancer Met... Solid Tumor, Ad... Advanced Cancer Lung Cancer, Sm... Metastatic Colo... Metastatic Rena... Metastatic Hepa... Metastatic Sarc... Metastatic Oste... | KB707 | 18 Years - | Krystal Biotech, Inc. | |
| Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma | NCT04668300 | Metastatic Angi... Metastatic Dedi... Metastatic Oste... Recurrent Angio... Recurrent Dedif... Recurrent Osteo... Refractory Dedi... Refractory Oste... | Durvalumab Oleclumab | 12 Years - | M.D. Anderson Cancer Center | |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | NCT00550654 | Kidney Cancer Melanoma (Skin) Metastatic Canc... Ovarian Cancer Sarcoma Unspecified Adu... | questionnaire a... 3-dimensional c... hypofractionate... image-guided ra... tomotherapy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | NCT00742924 | Sarcoma | cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate zoledronic acid adjuvant therap... neoadjuvant the... therapeutic con... filgrastim Mesna | - 40 Years | Children's Oncology Group | |
| Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma | NCT01016015 | Metastatic Oste... Recurrent Adult... Recurrent Osteo... Stage III Adult... Stage IV Adult ... | Cixutumumab Laboratory Biom... Temsirolimus | 16 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | NCT00003776 | Sarcoma | filgrastim cisplatin doxorubicin hyd... ifosfamide leucovorin calc... methotrexate trimetrexate gl... surgical proced... | - 30 Years | Memorial Sloan Kettering Cancer Center | |
| Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma | NCT01062438 | Sarcoma | DNA analysis RNA analysis gene expression... gene rearrangem... mutation analys... laboratory biom... | - | Children's Oncology Group | |
| Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma | NCT01886105 | Metastatic Oste... | Sm-EDTMP Autologous Stem... External Beam R... | 10 Years - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma | NCT01804374 | Metastatic Oste... Relapsed Osteos... | Sorafenib Everolimus | 18 Years - | Italian Sarcoma Group | |
| A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma | NCT05691478 | High Grade Oste... Localized Osteo... Metastatic Oste... Secondary Osteo... | Bone Scan Cabozantinib S-... Cisplatin Computed Tomogr... Doxorubicin Hyd... Magnetic Resona... Methotrexate Surgical Proced... X-Ray Imaging | - 40 Years | National Cancer Institute (NCI) | |
| Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma | NCT00066365 | Metastatic Canc... Sarcoma | sargramostim conventional su... | - 39 Years | Children's Oncology Group | |
| Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma | NCT00245011 | Sarcoma | filgrastim ifosfamide peripheral bloo... Sm-EDTMP (low d... sm-EDTMP (highe... | 13 Years - 50 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma | NCT01062438 | Sarcoma | DNA analysis RNA analysis gene expression... gene rearrangem... mutation analys... laboratory biom... | - | Children's Oncology Group | |
| Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma | NCT00026416 | Sarcoma | recombinant int... thalidomide adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery | NCT01553539 | Bone Cancer Chondrosarcoma Clear Cell Sarc... Metastatic Oste... Ovarian Sarcoma Recurrent Adult... Recurrent Osteo... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin... | therapeutic ang... laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma | NCT02243605 | Metastatic Ewin... Metastatic Oste... Recurrent Ewing... Recurrent Osteo... Stage III Osteo... Stage IV Osteos... Stage IVA Osteo... Stage IVB Osteo... Unresectable Ew... Unresectable Os... | Cabozantinib S-... Laboratory Biom... | 12 Years - | National Cancer Institute (NCI) | |
| A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors | NCT05135975 | Neuroblastoma Sarcoma | Cabozantinib | 18 Months - 40 Years | Nationwide Children's Hospital | |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
| Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma | NCT00023998 | Metastatic Oste... | doxorubicin hyd... cisplatin methotrexate leucovorin calc... filgrastim therapeutic con... radiation thera... etoposide ifosfamide trastuzumab laboratory biom... | - 30 Years | National Cancer Institute (NCI) | |
| Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma | NCT01062438 | Sarcoma | DNA analysis RNA analysis gene expression... gene rearrangem... mutation analys... laboratory biom... | - | Children's Oncology Group | |
| Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | NCT00742924 | Sarcoma | cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate zoledronic acid adjuvant therap... neoadjuvant the... therapeutic con... filgrastim Mesna | - 40 Years | Children's Oncology Group | |
| Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy | NCT00716976 | Brain Tumor Central Nervous... Childhood Germ ... Extragonadal Ge... Liver Cancer Neuroblastoma Ototoxicity Ovarian Cancer Sarcoma | sodium thiosulf... examination | 1 Year - 18 Years | Children's Oncology Group | |
| A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors | NCT05135975 | Neuroblastoma Sarcoma | Cabozantinib | 18 Months - 40 Years | Nationwide Children's Hospital | |
| Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas | NCT01807052 | Localized Osteo... Metastatic Oste... Recurrent Osteo... | laboratory biom... | - 39 Years | Children's Oncology Group | |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | NCT00550654 | Kidney Cancer Melanoma (Skin) Metastatic Canc... Ovarian Cancer Sarcoma Unspecified Adu... | questionnaire a... 3-dimensional c... hypofractionate... image-guided ra... tomotherapy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Alanosine in Treating Patients With Cancer | NCT00062283 | Lung Cancer Malignant Mesot... Pancreatic Canc... Sarcoma | L-alanosine | 13 Years - | National Cancer Institute (NCI) | |
| Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma | NCT00005625 | Sarcoma | trabectedin | 12 Years - | Memorial Sloan Kettering Cancer Center | |
| Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma | NCT00026416 | Sarcoma | recombinant int... thalidomide adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Blood Samples From Patients With Osteosarcoma | NCT00954473 | Localized Osteo... Metastatic Oste... Recurrent Osteo... | laboratory biom... | - | Children's Oncology Group | |
| Indo-cyanine Green (ICG) in Paediatric Oncology MIS | NCT04854018 | Pediatric Renal... Metastatic Oste... Metastatic Ewin... Pulmonary Metas... Rhabdomyosarcom... Non-Rhabdo. Sof... | Indocyanine gre... | 1 Day - 15 Years | Birmingham Women's and Children's NHS Foundation Trust | |
| Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer | NCT00003023 | Neuroblastoma Sarcoma | BCG vaccine monoclonal anti... | - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma | NCT00134030 | Localized Osteo... Metastatic Oste... | Cisplatin Doxorubicin Hyd... Etoposide Ifosfamide Methotrexate Peginterferon A... Quality-of-Life... Questionnaire A... Therapeutic Con... | 5 Years - 40 Years | Children's Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
